GENE ONLINE|News &
Opinion
Blog

Monoclonal Antibody
Korean Firm, Asia’s First to Get FDA Clearance for Testing Anti-Cancer Microbiome Therapeutic
2020-04-24
LEO Pharma Strikes Deal with Asian Firms to Develop Atopic Dermatitis & Allergic Asthma Drug
2020-04-17
Beigene’s Tislelizumab-Chemo Combo Nails Primary Endpoint in Phase 3 Trial
2020-04-16
GSK Reports Positive Results for Nucala in Patients with Nasal Polyps
2020-04-05
Roche Identifies Biomarker that Determines Patient Response to Immunotherapy
2020-03-15
Vir Biotechnology Stocks Raise after COVID-19 Partnership with Biogen
2020-03-12
Rapid Diagnosis: Academia Sinica’s New COVID-19 Detection Kit Augurs well for Combating the Epidemic
2020-03-10
Gilead Strikes US$ 4.9B Takeover Deal of Forty Seven
2020-03-02
Weekly in Asia|Nov-1
2019-11-19
Tecentriq/Arbaxane Combo Becomes the First FDA Approved Immunotherapy Regimen for Breast Cancer Treatment
2019-03-14
Weekly Top 5 in China (0224-0302)
2019-03-11
Herceptin Hylecta bags FDA approval for HER2-Positive Breast Cancer Treatment
2019-03-04
Weekly Top 5 in China (0127-0202)
2019-01-29
Tecentriq bags yet another FDA approval, this time as a combo therapy for NSCLC
2018-12-24
Novartis’s Ligelizumab Progresses to Phase III Trial
2018-12-17
1 3 4 5 6
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top